Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 309-312, 2003; 10.1373/49.2.309
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, L. A.
Right arrow Articles by Artlett, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, L. A.
Right arrow Articles by Artlett, C. M.
Related Collections
Right arrow Clinical Immunology
Right arrow Molecular Diagnostics and Genetics
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:309-312.)
© 2003 American Association for Clinical Chemistry, Inc.

Technical Briefs

Detection of Microchimeric Cells in the Peripheral Blood of Nonpregnant Women Is Enhanced by Magnetic Cell Sorting before PCR

Lori A. Cox, Ronald C. Ramos, Tara N. Dennis, Sergio A. Jimenez, J. Bruce Smith and Carol M. Artletta

1 Thomas Jefferson University, Department of Medicine, Division of Rheumatology, Philadelphia, PA 19107;

aaddress correspondence to this author at: Thomas Jefferson University, Department of Medicine, Division of Rheumatology, Room 509, Bluemle Lifesciences Bldg., 233 South 10th St., Philadelphia, PA 19107-5541, e-mail Carol.Artlett@mail.tju.edu

The first 300 words of the full text of this article appear below.

Our laboratory and others have demonstrated the presence of microchimeric cells in the peripheral blood of nonpregnant patients with systemic sclerosis (SSc) (1)(2)(3)(4). In addition, we have demonstrated the presence of maternal microchimeric cells in the peripheral blood of patients with juvenile idiopathic inflammatory myopathies (5), an observation confirmed in a subsequent study (6). However, some recent reports describe the failure to demonstrate the presence of male microchimeric cells in the peripheral blood of women with SSc or myopathies (7)(8)(9)(10). These latter studies used PCR amplification (9) or nested PCR (7)(8)(10) of Y-chromosome DNA sequences in whole peripheral blood.

Various PCR methods have been used for detection of microchimeric cell DNA in peripheral blood. These methods have been applied primarily to studies of organ transplantation or prenatal diagnosis (11)(12)(13)(14). However, the reliable detection and quantification of minute amounts of microchimeric DNA within a large pool of recipient DNA has been problematic. The need to limit the amount of autologous DNA in PCR analyses is likely to be an important determinant of the lower limit of detection for minor nonautologous cell populations. Numerous methods have been used for the detection of fetal cells for prenatal diagnosis in the peripheral blood of pregnant women; however, magnetic cell sorting is the most commonly used (15). Magnetic cell sorting for fetal erythroblasts has been used extensively in the analysis of peripheral blood of pregnant women (16)(17)(18), and this approach (18)(19) enriched the fetal cells ~200-fold (17).

We examined whether magnetic cell sorting to isolate . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.